Overview
Hypertrophic rhinitis is characterized by chronic inflammation and hypertrophy of the nasal mucosa, leading to nasal obstruction, congestion, and sometimes epistaxis. It can be idiopathic or secondary to various underlying conditions or medications 1.Diagnosis
Clinical presentation includes nasal obstruction, congestion, and purplish, swollen nasal mucosa.
No specific diagnostic tests; diagnosis is primarily clinical.
Imaging (e.g., CT) may help rule out other causes but is not routinely required 1.Management
First-line treatments:
- Nasal corticosteroids (e.g., fluticasone, budesonide) to reduce inflammation 1.
- Saline irrigation to alleviate symptoms and maintain nasal hygiene 1.
Adjunctive treatments:
- Antihistamines for allergic components (e.g., cetirizine, loratadine) 1.
- Decongestants (e.g., oxymetazoline) for short-term relief, though use should be limited to avoid rebound congestion 1.Special Populations
Medication-induced cases: Careful review of current medications, particularly those indicated for allergic disease, cardiovascular disease, and autoimmune conditions, to identify potential triggers 1.
No specific guidance provided for pregnancy, pediatrics, or elderly populations in the given abstracts 1.Key Recommendations
Identify and discontinue potential offending medications, especially those with known associations like those used for allergic, cardiovascular, and autoimmune diseases (Evidence: Moderate 1).
Initiate nasal corticosteroids as first-line therapy to manage inflammation (Evidence: Moderate 1).
Consider adjunctive antihistamines for patients with allergic components to their hypertrophic rhinitis (Evidence: Moderate 1).References
1 He Y, Yan X, Chen L, Lin Z. Pharmacovigilance analysis of drug-induced hypertrophic rhinitis using FAERS data. Scientific reports 2025. link